Powder: -20°C for 3 years
In solvent: -80°C for 2 years
PRN1008 is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM).
Description | PRN1008 is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM). |
Targets&IC50 | TEC:0.8 nM, Bmx:1.0 nM, Itk:440 nM, ErbB2:3900 nM, BTK:1.3 nM, ErbB4:11.3 nM, BLK:6.3 nM, EGFR:520 nM, RLK:1.2 nM |
Synonyms | PRN-1008, inhibit, PRN1008, Rilzabrutinib, PRN 1008, Inhibitor, Btk, Bruton tyrosine kinase |
Molecular Weight | 665.76 |
Formula | C36H40FN9O3 |
CAS No. | 1575596-29-0 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 130 mg/mL (195.27 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.